Mice deficient small heterodimer partner (SHP) are protected from diet induced hepatic steatosis due to increased fatty acid oxidation and decreased lipogenesis. The decreased lipogenesis appears to be a direct consequence of very low expression of peroxisome proliferator activated receptor gamma 2 (PPARγ2), a potent lipogenic transcription factor, in the SHP−/− liver. The current study focuses on the identification of a SHP dependent regulatory cascade that controls PPARγ2 gene expression, thereby regulating hepatic fat accumulation. Illumina BeadChip array and real-time polymerase chain reaction were used to identify genes responsible for the linkage between SHP and PPARγ2 using hepatic RNAs isolated from SHP−/− and SHP-overexpressing mice. The initial efforts identify that hairy and enhancer of split 6 (Hes6), a novel transcriptional repressor, is an important mediator of the regulation of PPARγ2 transcription by SHP. The Hes6 promoter is specifically activated by the retinoic acid receptor (RAR) in response to its natural agonist ligand all-trans retinoic acid (atRA), and is repressed by SHP. Hes6 subsequently represses hepatocyte nuclear factor 4 alpha (HNF4α) activated-PPARγ2 gene expression via direct inhibition of the HNF4α transcriptional activity. Furthermore, we provide evidences that atRA treatment or adenovirus-mediated RARα overexpression significantly reduced hepatic fat accumulation in obese mouse models as observed in earlier studies and the beneficial effect is achieved via the proposed transcriptional cascade. Conclusions Our study describes a novel transcriptional regulatory cascade controlling hepatic lipid metabolism that identifies retinoic acid signaling as a new therapeutic approach to non-alcoholic fatty liver diseases.
Mice deficient orphan nuclear receptor Small Heterodimer Partner (SHP) are protected from diet‐induced hepatic steatosis due to increased fatty acid oxidation and decreased lipogenesis. Especially the mice exhibited very low expression of peroxisome proliferator activated receptor gamma 2 (Pparγ2), a potent adipogenic transcription factor, in the liver after long‐term western diet (WestD) regimen. We have identified a hairy and enhancer split 6 (Hes6), a novel transcriptional repressor, as an important mediator for the regulation of Pparγ2 expression by SHP using Illumina Beadchip array and realtime PCR analysis in the RNAs isolated from livers of SHP‐/‐ and SHP‐overexpressing mice. The repression of Pparγ2 expression by Hes6 is achieved via its direct repression of hepatocyte nuclear factor 4 alpha (Hnf4α) transcriptional activity. The Hes6 promoter is specifically activated by the retinoic acid receptor (RAR) in response to its natural agonist all‐trans retinoic acid (atRA), and is repressed by SHP. Treatment of atRA or adenovirus‐mediated RARα overexpression in obese mice increased Hes6 mRNA levels and significantly reduced hepatic fat accumulation along with the decreased expression of Pparγ2 and its downstream target gene, fat specific protein 27 (Fsp27). Furthermore, adenovirus‐mediated Hes6 overexpression significantly reduced triglyceride concentration and the expression of Pparγ2 and Fsp27 in the livers of WestD‐fed mice. The current study identifies a novel transcriptional regulatory cascade controlling lipid metabolism and provides insights into new therapeutic approaches to fatty liver diseases. Grant Funding Source: This study is supported by NIH grant R01DK093774.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.